| NCCN Collaborates in the Middle East & North Africa Region |
 |
The 2012 Middle East & North Africa (MENA) Congress was held in Doha, Qatar on January 26-28. This Congress focused on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer and Non-Small Cell Lung Cancer, with a special additional workshop illustrating the NCCN Guidelines processes and applications. More than 250 oncology professionals from across the MENA region attended the three days of intensive education and discussion surrounding the NCCN Guidelines and their application in MENA practices. Hamdy Azim, MD, of Cairo University opened the program on January 26 by describing the history of NCCN's work in the region and the goal of continued, annual collaborations by which NCCN experts contribute their time and expertise to the betterment of lives of patients with cancer in the Middle East. It was noted that the NCCN Guidelines have emerged as a very useful tool for improving the quality of decision-making for oncology professionals in the region.
|
 |
| NCCN Holds Joint Seminar with JCCNB |
 |
The 2012 NCCN/Japan Comprehensive Cancer Network, Breast (JCCNB) Seminar was held in Tokyo, Japan on April 15, 2012. The Seminar featured presentations focused on various aspects of ductal carcinoma in situ (DCIS) from Benjamin Anderson, MD, of Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, D. Craig Allred, MD, of Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Rie Horri, MD, PhD, of Cancer Institute Hospital, Japanese Foundation for Cancer Research, and Chiun-Sheng Huang, MD, PhD, MPH, of National Taiwan University. Joan McClure, MS, of NCCN presented on data requirements for inclusion in the NCCN Guidelines and E.S. Lee, MD, PhD, of Korea University presented recent breast cancer data from the Korean Breast Cancer Society.
|
|
 |
New Japanese Translations of the NCCN Guidelines Available
|
NCCN recently posted four additional Japanese translations of the NCCN Guidelines®. The new translations include Malignant Pleural Mesothelioma, Occult Primary, Pancreatic Adenocarcinoma, and Thymomas and Thymic Carcinomas. NCCN supports the Translational Research Informatics (TRI) Center as they endeavor to translate the Complete Library of NCCN Guidelines into non-adapted Japanese translations. Each NCCN translation is overseen by the appropriate medical society in Japan to ensure its accuracy for use by Japanese clinicians in the treatment of their patients.
There are currently 20 NCCN Guidelines available in Japanese on NCCN.org. The addition of these translations further strengthens NCCN's commitment to improving the quality and effectiveness of cancer care regardless of language or geographic barriers.
Translations of NCCN Guidelines are available in Chinese, Japanese, South Korean, Spanish, and Portuguese. Additionally, adaptations of NCCN Guidelines are available for use in Asia, China, the Middle East and North Africa region, and the Republic of South Korea. To access these resources, or to learn more about NCCN international initiatives, please visit NCCN.org.
If you would like to learn more about translating the NCCN Guidelines, please contact Marisa Getzewich, Getzewich@nccn.org. |
|
| Online Education through NCCN Now Available |
 |
NCCN recently launched the NCCN Continuing Education Portal online learning management system. The mission of NCCN's Continuing Education Program is to improve patient outcomes in oncology by educating clinicians on the application of evidence-based medicine. Our accredited educational activities are designed for oncologists (in both community and academic settings), nurses, pharmacists, case managers, and other health care professionals involved in the care of patients with cancer.
The content of our activities focuses on the professional scope of patient care, as continually identified through analysis of professional knowledge and practice gaps, as well as educational needs. Our activities achieve results measured through documented increases in learners' knowledge, competence and performance.
We offer activities in a number of formats including live conferences and symposia, live webinars, online webcasts, flash drives, and journal supplements/monographs appearing in JNCCN — Journal of the National Comprehensive Cancer Network. Presentations address a wide range of learning styles, often combining dynamic lectures, interactive group discussions and case studies that allow participants to interact with faculty and provide many opportunities for question and answer encounters with presenters.
Through this system, learners are able register for live courses, participate in free online CE, search for courses in specific interest areas, receive electronic certificates automatically, and track all NCCN CE with a personalized transcript. Current programs available include archived materials from the NCCN 17th Annual Conference and the NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology.
|
|
No hay comentarios:
Publicar un comentario